ArticleTheranostics2022

Erratum: Inhibition of SMYD2 suppresses tumor progression by down-regulating microRNA-125b and attenuates multi-drug resistance in renal cell carcinoma: Erratum.

Libin Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.